European Medicines Agency confident vaccines for Indian strain are effective

By TPN/Lusa, in News, COVID-19 · 13-05-2021 08:00:00 · 0 Comments

The European Medicines Agency (EMA) has said it is confident that the vaccines currently used in the European Union protect against the variant discovered in India of the SARS-CoV-2 coronavirus, which causes Covid-19.

"So far, overall, we are fairly confident that the vaccines generally cover this variant," Marco Cavaleri, the agency's head for vaccination strategy, told a virtual press conference.

Cavaleri said that "the data seems pretty secure in the sense that at least the vaccine with 'messenger RNA' (mRNA) technology will be effective in neutralising this variant, at least ensuring sufficient protection" against the disease, he reinforced.

The director of the department of Biological Health Threats and Vaccine Strategy indicated that the EMA also hopes that "the viral vector vaccine will also be effective", noting that more data collected in India, where Astrazeneca's viral vector vaccine is being used, is awaited.

When asked about the analysis of the Russian Sputnik V vaccine, which has not yet been authorised for use by the EMA, Marco Cavaleri said that inspections of good manufacturing practice and good clinical production practice are ongoing, and that a timetable for potential approval for use in the European Union could be set "in the coming weeks".

Regarding the Chinese Sinovac, Cavaleri pointed out that the agency is still deciding when elements can be sent for analysis.



Related articles


Comments:

Be the first to comment on this article
Interactive Topics, send us your comments/opinion on this article.

Please note that The Portugal News may use selected comments in the printed edition of the newspaper.